Condition: Persian Gulf Syndrome · Gulf War Syndrome · Multiple Chronic Illnesses · Sponsor: University of Utah
This unblinded Phase II clinical trial will test the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners will have had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness will be randomized to either six months of biweekly acupuncture treatments (group 1, n=100) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=100). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).
This description comes directly from the study's public registry record.
Lisa Conboy · 617-718-1917 · lisa_conboy@hms.harvard.edu
Always discuss trial participation with your own doctor first.
| University of California, Berkeley | Berkeley, California, United States | Not Yet Recruiting |
| Various | Los Angeles, California, United States | Recruiting |
| Various | Colorado Springs, Colorado, United States | Not Yet Recruiting |
| Various | Denver, Colorado, United States | Not Yet Recruiting |
| Various | Tampa, Florida, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| Various | Dallas, Texas, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Not Yet Recruiting |
| Various | Fairfax, Virginia, United States | Not Yet Recruiting |
| Various | Seattle, Washington, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06716411